+1-888-308-5802     
News Contact Us

Lyndra Therapeutics to develop ‘once-a month’ birth control pills

Author : Saif Ali Bepari | Published Date : 2019-07-31 
  • The company has received a grant of USD 13 Million from the Bill and Melinda Gates Foundation.
  • This grant focuses upon meeting the unmet therapeutic needs for women health.

Lyndra Therapeutics, the company that has literally rendered daily pills obsolete, has reportedly announced receiving a USD 13 million grant from the Bill & Melinda Gates Foundation for the development of an oral contraceptive which is expected to last for over a month.

As per the authentic sources, the endowment is a part of the Bill and Melinda Gates Family Planning program, which is currently working on providing access to high-quality contraceptive information, facilities and supplies to women in low- and middle-income countries.

According to the industry experts nearly 214 mn women of reproductive age in developing regions are avoiding the use of contraceptives as of 2017. Amongst the estimated 206 million pregnancies reported in 2017 in the developing nations, 43% were unplanned, and the care expenses related to these pregnancies approximately adds up to USD 8.3 billion yearly.

Amy Schulman, CEO & co-creator of Lyndra Therapeutics was reportedly quoted stating that the 13-million-dollar grant was special to the company as it extends their focus on addressing the unmet therapeutic needs into women health. The company is also gratified to be associated with the Bill and Melinda Gates Foundation’s attempts to improve the lives of women and ensure proper health conditions.

Reportedly, with the funds collected, Lyndra is currently designing and structuring a new once-a month oral combination therapy that produces a continuous dosage of estrogen and progestin, which are used in everyday combined oral contraceptives. The development program is focused on demonstrating that once-monthly residence is achievable which includes preclinical evaluation conducted in collaboration with a non-profitable social and public health research organization- Routes2Results with extensive regional expertise, through additional funding from the foundation.

Headquartered in USA, Lyndra Therapeutics aims to advance the healthcare outcomes through oral therapies that change the way people take medicines.

Source credit: https://finance.yahoo.com/news/lyndra-therapeutics-develop-once-monthly-040100614.html

About Author

Saif Ali Bepari

Saif Ali Bepari

A qualified Computer Science graduate, Saif Ali Bepari, armed with more of an inclination toward writing than coding, commenced his journey in the content industry as a freelancer. Currently penning down content for fractovia.org and a couple of other portals, Saif has also tinkered with creative writing, technical writing, blog writing, and copywriting. He can be contacted at- [email protected] | https://twitter.com/Saif_B17

Related News

Co-working firm Spacious the latest in WeWork’s acquisition spree

Published Date: 2019-08-29         Author: Saif Ali Bepari

New York-based co-working business, The We Company, formerly known as WeWork, has today announced its acquisition of rival start-up Spacious. The company, formed three years ago, is focused on converting restaurants closed during the day into efficient spaces for co-working. WeWork is a part of many... Read More

HAPSMobile wins federal approval to fly unmanned aircraft above Hawaii

Published Date: 2019-08-09         Author: Saif Ali Bepari

The development of HAWK30 focuses on providing an enhanced stratospheric telecommunication platform Japan based HAPSMobile- a subsidiary of SoftBank Corp., has reportedly confirmed that it has received an Authorizing Certificate from US Federal Aviation Administration to fly HAWK 30, a solar oper... Read More

FEMSA to ink joint venture deal with Raizen Conveniencias in Brazil

Published Date: 2019-08-07         Author: Saif Ali Bepari

Mexico based Fomento Economico Mexicano (FEMSA), a leading retail and beverage company, has reportedly announced that it will sign an agreement with Raizen to enter into a 50-50 joint venture. The collaboration aims at creating a powerful platform for FEMSA in the convenience store market in Brazil ... Read More

© 2019 Fractovia. All Rights Reserved